Healthcare -
Biotechnology - NASDAQ - US
$ 7.72
-4.1 %
$ 5.38 M
Market Cap
0.0
P/E
RNAZ - LONG-TERM DEBT
Long-term Debt RNAZ - TransCode Therapeutics, Inc.
38.3 K
LAST VALUE
0.00%
2 YEAR CAGR
-38.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR